alexa
Reach Us +1-217-403-9671
Ethnopharmacology And Metabolomics: A Multidisciplinary Approach For Drug Discovery From Natural Sources | 7517
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Ethnopharmacology and metabolomics: A multidisciplinary approach for drug discovery from natural sources

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

U.K. Patil

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Abstract
Phytochemical screening techniques are developing fast and we now have tools available which allow us to analyse complex mixtures in ultra modern ways. The modern research era allows a systematic investigation of such complex mixtures and specifically to link phytochemical analysis with other strategies (such as in vitro or in vivo screening for biological activity or toxicity, morphological plant diversity and ecological parameters). Specifically as it relates to the study of medicinal and food plants, the main challenge is to understand the complex effects of such extracts. Since most of these research activities are linked to plants used in traditional and local cultures, this requires an ethno-pharmacological approach coupled with modern metabolomic investigations. The potential of such multidisciplinary approach and its potential benefits for phytochemically oriented research will be discussed. The traditional medicines offer a rich and largely unexplored source of therapeutic leads for the pharmaceutical industry. Academic research and the pharmaceutical sciences may profit in many ways by including ethnopharmacological and metabolomic investigations. One highly illuminating example is the acetylcholine-esterase inhibitor galanthamine. The early research into the botanical species was derived from Galanthus species. It was based on local, but poorly documented knowledge, which was then turned into a medication to treat poliomyelitis and ultimately resulted in a novel treatment of Alzheimer?s disease. Although herbal medicinal products (HMP) have been perceived by the public as relatively low risk, there has been more recognition of the potential risks associated with this type of product as the use of HMPs increases. Potential harm can occur via inherent toxicity of herbs, as well as from contamination, adulteration, plant misidentification, and interactions with other herbal products or pharmaceutical drugs. Regulatory safety assessment for HMPs relies on both the assessment of cases of adverse reactions and the review of published toxicity information. However, the conduct of such an integrated investigation has many challenges in terms of the quantity and quality of information. Adverse reactions are under-reported, product quality may be less than ideal, herbs have a complex composition and there is lack of information on the toxicity of medicinal herbs or their constituents. Nevertheless, opportunities exist to capitalise on newer information to increase the current body of scientific evidence. The integration of ethnopharmacology and metabolomics can reduce the uncertainty in decision making with respect to herbal medicinal products.
Biography
Patil has completed his Ph.D from Dr. H.S. Gour University, Sagar, India and postdoctoral studies from Leiden University Institute of Biology, The Netherlands. He has 16 years experience of education and research & development on safety and toxicity of Herbal Medicinal Prodcucts (HMPs). He is the Dean, Faculty of Pharmacy of People?s University, Bhopal, India. He has published more than 75 papers in reputed journals and serving as editorial board member of many reputed journals. Prof. Patil is member of many professional bodies including GA, ICMAP, ISE, FIP, ISNPD, IPA, APTI, IPA, ISP, IAHP etc.
Top